The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global MRI Contrast Agents Market Research Report 2025
Synopsis
MRI contrast agents are contrast agents used to improve the visibility of internal body structures in magnetic resonance imaging (MRI). The most commonly used compounds for contrast enhancement are gadolinium-based. Such MRI contrast agents shorten the relaxation times of nuclei within body tissues following oral or intravenous administration.
The global MRI Contrast Agents market was valued at US$ 1384.9 million in 2023 and is anticipated to reach US$ 2110.2 million by 2030, witnessing a CAGR of 5.9% during the forecast period 2024-2030.
Global key MRI contrast agents core players include Bayer, Guerbet Group and Bracco Imaging etc. The top 3 companies hold a share about 82%. Asia-Pacific is the largest market with a share about 35%, followed by North America and Europe.
In terms of product, gadoterate meglumine product is the largest segment with a share about 27%. And in terms of applications, the largest application is hospital with a share about 84%.
This report aims to provide a comprehensive presentation of the global market for MRI Contrast Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding MRI Contrast Agents.
Report Scope
The MRI Contrast Agents market size, estimations, and forecasts are provided in terms of sales volume (Liter) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global MRI Contrast Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the MRI Contrast Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Guerbet Group
Bracco Imaging
GE Healthcare
BeiLu Pharma
Hengrui Medicine
Segment by Type
Gadobutrol
Gadoterate Meglumine
Gadobenate Dimeglumine
Gadopentetate Dimeglumine
Gadoteridol
Gadodiamine
Others
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of MRI Contrast Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of MRI Contrast Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
MRI contrast agents are contrast agents used to improve the visibility of internal body structures in magnetic resonance imaging (MRI). The most commonly used compounds for contrast enhancement are gadolinium-based. Such MRI contrast agents shorten the relaxation times of nuclei within body tissues following oral or intravenous administration.
The global MRI Contrast Agents market was valued at US$ 1384.9 million in 2023 and is anticipated to reach US$ 2110.2 million by 2030, witnessing a CAGR of 5.9% during the forecast period 2024-2030.
Global key MRI contrast agents core players include Bayer, Guerbet Group and Bracco Imaging etc. The top 3 companies hold a share about 82%. Asia-Pacific is the largest market with a share about 35%, followed by North America and Europe.
In terms of product, gadoterate meglumine product is the largest segment with a share about 27%. And in terms of applications, the largest application is hospital with a share about 84%.
This report aims to provide a comprehensive presentation of the global market for MRI Contrast Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding MRI Contrast Agents.
Report Scope
The MRI Contrast Agents market size, estimations, and forecasts are provided in terms of sales volume (Liter) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global MRI Contrast Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the MRI Contrast Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Guerbet Group
Bracco Imaging
GE Healthcare
BeiLu Pharma
Hengrui Medicine
Segment by Type
Gadobutrol
Gadoterate Meglumine
Gadobenate Dimeglumine
Gadopentetate Dimeglumine
Gadoteridol
Gadodiamine
Others
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of MRI Contrast Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of MRI Contrast Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 MRI Contrast Agents Market Overview
1.1 Product Overview and Scope of MRI Contrast Agents
1.2 MRI Contrast Agents Segment by Type
1.2.1 Global MRI Contrast Agents Market Value Comparison by Type (2024-2030)
1.2.2 Gadobutrol
1.2.3 Gadoterate Meglumine
1.2.4 Gadobenate Dimeglumine
1.2.5 Gadopentetate Dimeglumine
1.2.6 Gadoteridol
1.2.7 Gadodiamine
1.2.8 Others
1.3 MRI Contrast Agents Segment by Application
1.3.1 Global MRI Contrast Agents Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global MRI Contrast Agents Market Size Estimates and Forecasts
1.4.1 Global MRI Contrast Agents Revenue 2019-2030
1.4.2 Global MRI Contrast Agents Sales 2019-2030
1.4.3 Global MRI Contrast Agents Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 MRI Contrast Agents Market Competition by Manufacturers
2.1 Global MRI Contrast Agents Sales Market Share by Manufacturers (2019-2024)
2.2 Global MRI Contrast Agents Revenue Market Share by Manufacturers (2019-2024)
2.3 Global MRI Contrast Agents Average Price by Manufacturers (2019-2024)
2.4 Global MRI Contrast Agents Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of MRI Contrast Agents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of MRI Contrast Agents, Product Type & Application
2.7 MRI Contrast Agents Market Competitive Situation and Trends
2.7.1 MRI Contrast Agents Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest MRI Contrast Agents Players Market Share by Revenue
2.7.3 Global MRI Contrast Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 MRI Contrast Agents Retrospective Market Scenario by Region
3.1 Global MRI Contrast Agents Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global MRI Contrast Agents Global MRI Contrast Agents Sales by Region: 2019-2030
3.2.1 Global MRI Contrast Agents Sales by Region: 2019-2024
3.2.2 Global MRI Contrast Agents Sales by Region: 2025-2030
3.3 Global MRI Contrast Agents Global MRI Contrast Agents Revenue by Region: 2019-2030
3.3.1 Global MRI Contrast Agents Revenue by Region: 2019-2024
3.3.2 Global MRI Contrast Agents Revenue by Region: 2025-2030
3.4 North America MRI Contrast Agents Market Facts & Figures by Country
3.4.1 North America MRI Contrast Agents Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America MRI Contrast Agents Sales by Country (2019-2030)
3.4.3 North America MRI Contrast Agents Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe MRI Contrast Agents Market Facts & Figures by Country
3.5.1 Europe MRI Contrast Agents Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe MRI Contrast Agents Sales by Country (2019-2030)
3.5.3 Europe MRI Contrast Agents Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific MRI Contrast Agents Market Facts & Figures by Country
3.6.1 Asia Pacific MRI Contrast Agents Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific MRI Contrast Agents Sales by Country (2019-2030)
3.6.3 Asia Pacific MRI Contrast Agents Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America MRI Contrast Agents Market Facts & Figures by Country
3.7.1 Latin America MRI Contrast Agents Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America MRI Contrast Agents Sales by Country (2019-2030)
3.7.3 Latin America MRI Contrast Agents Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa MRI Contrast Agents Market Facts & Figures by Country
3.8.1 Middle East and Africa MRI Contrast Agents Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa MRI Contrast Agents Sales by Country (2019-2030)
3.8.3 Middle East and Africa MRI Contrast Agents Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global MRI Contrast Agents Sales by Type (2019-2030)
4.1.1 Global MRI Contrast Agents Sales by Type (2019-2024)
4.1.2 Global MRI Contrast Agents Sales by Type (2025-2030)
4.1.3 Global MRI Contrast Agents Sales Market Share by Type (2019-2030)
4.2 Global MRI Contrast Agents Revenue by Type (2019-2030)
4.2.1 Global MRI Contrast Agents Revenue by Type (2019-2024)
4.2.2 Global MRI Contrast Agents Revenue by Type (2025-2030)
4.2.3 Global MRI Contrast Agents Revenue Market Share by Type (2019-2030)
4.3 Global MRI Contrast Agents Price by Type (2019-2030)
5 Segment by Application
5.1 Global MRI Contrast Agents Sales by Application (2019-2030)
5.1.1 Global MRI Contrast Agents Sales by Application (2019-2024)
5.1.2 Global MRI Contrast Agents Sales by Application (2025-2030)
5.1.3 Global MRI Contrast Agents Sales Market Share by Application (2019-2030)
5.2 Global MRI Contrast Agents Revenue by Application (2019-2030)
5.2.1 Global MRI Contrast Agents Revenue by Application (2019-2024)
5.2.2 Global MRI Contrast Agents Revenue by Application (2025-2030)
5.2.3 Global MRI Contrast Agents Revenue Market Share by Application (2019-2030)
5.3 Global MRI Contrast Agents Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer MRI Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer MRI Contrast Agents Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Guerbet Group
6.2.1 Guerbet Group Corporation Information
6.2.2 Guerbet Group Description and Business Overview
6.2.3 Guerbet Group MRI Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Guerbet Group MRI Contrast Agents Product Portfolio
6.2.5 Guerbet Group Recent Developments/Updates
6.3 Bracco Imaging
6.3.1 Bracco Imaging Corporation Information
6.3.2 Bracco Imaging Description and Business Overview
6.3.3 Bracco Imaging MRI Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bracco Imaging MRI Contrast Agents Product Portfolio
6.3.5 Bracco Imaging Recent Developments/Updates
6.4 GE Healthcare
6.4.1 GE Healthcare Corporation Information
6.4.2 GE Healthcare Description and Business Overview
6.4.3 GE Healthcare MRI Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GE Healthcare MRI Contrast Agents Product Portfolio
6.4.5 GE Healthcare Recent Developments/Updates
6.5 BeiLu Pharma
6.5.1 BeiLu Pharma Corporation Information
6.5.2 BeiLu Pharma Description and Business Overview
6.5.3 BeiLu Pharma MRI Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.5.4 BeiLu Pharma MRI Contrast Agents Product Portfolio
6.5.5 BeiLu Pharma Recent Developments/Updates
6.6 Hengrui Medicine
6.6.1 Hengrui Medicine Corporation Information
6.6.2 Hengrui Medicine Description and Business Overview
6.6.3 Hengrui Medicine MRI Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Hengrui Medicine MRI Contrast Agents Product Portfolio
6.6.5 Hengrui Medicine Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 MRI Contrast Agents Industry Chain Analysis
7.2 MRI Contrast Agents Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 MRI Contrast Agents Production Mode & Process
7.4 MRI Contrast Agents Sales and Marketing
7.4.1 MRI Contrast Agents Sales Channels
7.4.2 MRI Contrast Agents Distributors
7.5 MRI Contrast Agents Customers
8 MRI Contrast Agents Market Dynamics
8.1 MRI Contrast Agents Industry Trends
8.2 MRI Contrast Agents Market Drivers
8.3 MRI Contrast Agents Market Challenges
8.4 MRI Contrast Agents Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
